Advancing Efficient GPCR Drug Discovery via Computational Methods

webinar

Thu, 27 Mar 2025, 16:00 CET (Berlin)

Prof. Dr. Shuguang Yuan, Shenzhen University of Advanced Technology, Chinese Academy of Sciences, China

Advancing Efficient GPCR Drug Discovery via Computational Methods

Modern drug discovery is a long and tedious process which takes, on average, at least 10 years and 2 billion USD to bring a drug to market. One of the most critical challenges in our industry today is accelerating this costly process. With advancements in artificial intelligence and computational biology, computational pharmacy is now playing an increasingly important role in modern drug discovery.

In this talk, Dr. Yuan will illustrate computational biology and artificial intelligence applications to answer fundamental questions in life science, especially in the area of G protein-coupled receptors (GPCRs). He will also discuss how to speed up modern drug discovery in an ultimately efficient way. Finally, Dr. Yuan will share his personal success story of developing “first-in-class” drug molecules and advancing them into clinical trials.

Current news

VAST Just Got Bigger — The September 2026 Update
September 17, 2026 09:00 CEST
More compounds. More chemistry. More opportunities to discover your next active. This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. XtalPi has expanded its VAST Chemical Space, giving you access to almost six billion virtual product molecules built from over 25,000 carefully selected...
Read on
category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on
category
Events
Beyond the Flatland: sp³-Rich Fragments Unlock Novel Kinase Chemotypes: Free Webinar!
September 15, 2026 10:40 CEST
Kinases are among the most intensively pursued target families in drug discovery, yet the chemical matter screened against them remains surprisingly narrow. Conventional kinase-focused libraries are dominated by flat, heteroaromatic compounds, while saturated, three-dimensional molecules stay largely underexplored. That narrow structural diversity makes it harder to find genuinely novel chemotypes,...
Read on